August 18, 2017 1:09 AM ET


Company Overview of LeukoSite, Inc.

Company Overview

As of December 22, 1999, LeukoSite, Inc. was acquired by Millennium Pharmaceuticals Inc. LeukoSite, Inc. developed small molecule and monoclonal antibody therapeutics for inflammatory, autoimmune, and viral diseases, as well as for cancer applications, as of September 30, 1999. Its products included CAMPATH™ for the treatment of chronic lymphocytic leukemia, LDP-02 for the treatment of inflammatory bowel disease, LDP-01 for the prevention of post-ischemic reperfusion injury, and LDP-977 for the treatment of bronchial asthma. The company also had nine partner-funded research and discovery programs based on the selective blockade of specific chemokine, chemokine receptor, or integrin controlle...

215 First Street

Cambridge, MA 02142

United States



Key Executives for LeukoSite, Inc.

LeukoSite, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LeukoSite, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at